Babesia caballi: Equine Piroplasmosis in Horses, Tick-Borne Blood Parasite Diagnosis and Control

Introduction

Equine piroplasmosis is a tick-borne disease of horses, donkeys, mules, and other equids caused by the intraerythrocytic apicomplexan parasites Babesia caballi and Theileria equi (formerly Babesia equi). The disease is recognized globally as a constraint to international horse movement and poses a significant economic burden on the equine industry [1]. Babesia caballi is a true piroplasm that undergoes transovarial transmission in tick vectors, whereas T. equi is transmitted transstadially and has a distinct life cycle [1]. This article provides an exhaustive, publication-grade review of B. caballi infection, focusing on diagnosis and control, with reference exclusively to the available peer-reviewed literature [1-11].

Etiology and Life Cycle

Babesia caballi is a small (2-5 μm) pear-shaped merozoite that parasitizes equine erythrocytes. The life cycle involves definitive ixodid tick hosts and equine intermediate hosts. In the horse, sporozoites injected by feeding ticks invade red blood cells and undergo asexual multiplication (merogony), leading to hemolysis and clinical disease [1]. In the tick, sexual reproduction occurs in the gut, followed by invasion of hemolymph and salivary glands. Transovarial transmission is characteristic of B. caballi: infected female ticks pass the parasite to their offspring [1, 2]. The most important tick vectors belong to the genera Dermacentor, Rhipicephalus, and Hyalomma [1, 3]. The prepatent period in horses ranges from 10 to 30 days depending on the infective dose and host immunity [1].

Epidemiology

Babesia caballi is distributed across Africa, Asia, Europe, the Americas, and the Caribbean, with prevalence varying by geographic region, vector ecology, and horse management practices. In Paraguay, a molecular survey of apparently healthy horses using PCR targeting the 16S rRNA gene revealed a prevalence of 8.5% for B. caballi [4]. In Central Southern Italy, a comparison of direct (PCR) and indirect (IFAT, cELISA) methods showed that combined testing maximized detection, with B. caballi seroprevalence reaching 13.4% [5]. In Venezuela, sport horses examined by PCR exhibited a 3.3% prevalence of B. caballi, with clinical and cardiovascular findings including anemia and elevated cardiac biomarkers [6]. In Guadeloupe (Caribbean), molecular detection showed a B. caballi infection rate of 1.8%, and the study also reported the first detection of Theileria haneyi in the region, highlighting the impact of horse movement on parasite dissemination [7]. In Iran, 16.6% of horses were seropositive for B. caballi by IFAT, and the parasite was also detected in ticks of the genera Hyalomma and Rhipicephalus [3]. Age-dependent dynamics were demonstrated in Mongolia, where seroprevalence by IFAT increased with age, peaking at over 80% in horses older than 10 years, while PCR prevalence remained lower (approximately 20%) [8]. A clinical outbreak in Southern Romania confirmed acute B. caballi infection with severe anemia and hemoglobinuria [2].

Clinical Signs

The clinical spectrum of B. caballi infection ranges from subclinical to peracute disease. Acute cases are characterized by fever (often exceeding 40°C), hemolytic anemia, icterus, hemoglobinuria, depression, anorexia, and peripheral edema [1, 2]. In the Romanian outbreak, affected horses presented with fever, pale mucous membranes, and dark red urine; hematological findings included normocytic normochromic anemia and thrombocytopenia [2]. In Venezuelan sport horses, infected animals exhibited increased heart rate, elevated cardiac troponin I, and echocardiographic alterations consistent with myocardial stress [6]. Chronic infections may be subclinical, with low-level parasitemia that can recrudesce under stress or immunosuppression [1]. Carrier horses serve as a reservoir for tick vectors and are a major challenge for disease control and international trade [1].

Diagnosis

Accurate diagnosis of B. caballi infection is essential for clinical management, epidemiological surveillance, and prevention of disease spread. Each diagnostic method has specific advantages and limitations.

Microscopic Examination

Giemsa-stained blood smears are the simplest direct detection method, allowing visualization of intraerythrocytic merozoites [1]. However, sensitivity is low, especially in carrier animals with low parasitemia; multiple smears may be required [5].

Serological Methods

Indirect fluorescent antibody tests (IFAT) and competitive enzyme-linked immunosorbent assays (cELISA) detect anti-B. caballi antibodies. IFAT is considered a reference test by the World Organisation for Animal Health (WOAH) [1, 8]. Seroconversion occurs 1-3 weeks post-infection. The main limitation is the inability to distinguish active from past infection. In the Italian study, seropositivity by IFAT was 13.4% compared to 3.0% by PCR, reflecting the persistence of antibodies beyond parasite clearance [5].

Molecular Methods

Polymerase chain reaction (PCR) offers high sensitivity and specificity. Conventional PCR targeting the 16S rRNA gene was first validated for B. caballi by Bashiruddin et al. [9]. Duplex real-time PCR assays that simultaneously detect B. caballi and T. equi have been developed and validated, achieving analytical sensitivity as low as 1-10 copies/μL [10]. Isothermal amplification techniques, such as recombinase polymerase amplification (RPA), provide rapid, field-deployable diagnosis; a duplex real-time RPA assay for equine piroplasmosis demonstrated 100% sensitivity and specificity relative to qPCR [11]. In outbreak investigations, PCR is invaluable for confirming acute infection and identifying carriers [2]. Ticks collected from horses can also be tested by PCR to assess vector infection rates [3].

Comparison of Methods

A summary of diagnostic methods is presented in Table 1.

Table 1. Diagnostic methods for Babesia caballi infection in horses.

Diagnostic Workflow

A decision tree for diagnosing B. caballi infection is shown in Figure 1.

flowchart TD
 A["Equine patient: fever, anemia, icterus, or travel history"] --> B{Blood smear microscopy}
 B -->|Positive: piroplasms visible| C[Confirm with PCR]
 B -->|Negative or inconclusive| D["Serology: IFAT or cELISA"]
 D -->|Positive| E[PCR on blood and tick samples]
 D -->|Negative| F[Alternative diagnosis]
 C --> G[Species identification and reporting]
 E --> G
 G --> H[Implement tick control and treatment]
 F --> I["Monitor for recrudescence; consider repeat testing"]

Control and Prevention

Control of equine piroplasmosis relies on a combination of vector management, biosecurity, and therapeutic intervention.

Tick Vector Management

Reducing exposure to tick vectors is the cornerstone of prevention. Integrated control includes: (a) application of acaricides (e.g., pyrethroids, organophosphates) on horses and in stables, (b) pasture management to reduce tick habitat (mowing, rotation), (c) removal of brush and debris, and (d) inspection and manual removal of ticks. In endemic regions, year-round chemical control may be necessary [1].

Quarantine and Movement Restrictions

Imported horses should be tested prior to movement using a combination of serology and PCR. Carriers detected by PCR should be treated or denied entry. Seropositive horses (without detectable parasitemia) may be considered safe but should be monitored [7].

Treatment

The drug of choice for B. caballi is imidocarb dipropionate (two doses of 2.2 mg/kg intramuscularly at 24-48 hour intervals). This drug may eliminate parasitemia in many but not all horses; clearance should be confirmed by PCR 30 days post-treatment [1]. Supportive care (fluid therapy, blood transfusion in severe anemia) is indicated in acute cases.

Conclusions

Babesia caballi remains a globally important pathogen of horses, with significant implications for health and trade. Sensitive molecular tools including real-time PCR [10] and isothermal RPA assays [11] have greatly improved diagnostic capacity, especially in carrier detection. Integrated control combining acaricide use, quarantine, and treatment is essential to reduce disease burden and prevent spread via horse movement.

References

[1] Wise LN, Kappmeyer LS, Mealey RH, et al. Review of equine piroplasmosis. J Vet Intern Med. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/24033559/

[2] Ionita M, Nicorescu IM, Pfister K, et al. Parasitological and molecular diagnostic of a clinical Babesia caballi outbreak in Southern Romania. Parasitol Res. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29766270/

[3] Abedi V, Razmi G, Seifi H, et al. Molecular and serological detection of Theileria equi and Babesia caballi infection in horses and ixodid ticks in Iran. Ticks Tick Borne Dis. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/24556274/

[4] Ahedor B, Sivakumar T, Valinotti MFR, et al. PCR detection of Theileria equi and Babesia caballi in apparently healthy horses in Paraguay. Vet Parasitol Reg Stud Reports. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36878622/

[5] Nardini R, Cersini A, Bartolomé Del Pino LE, et al. Comparison of direct and indirect methods to maximise the detection of Babesia caballi and Theileria equi infections in Central Southern Italy. Ticks Tick Borne Dis. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35474261/

[6] Risso A, Campos G, Garcia H, et al. Insights into equine piroplasmosis in Venezuelan sport horses: Molecular diagnosis, clinical, and cardiovascular findings. Vet Parasitol Reg Stud Reports. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35012720/

[7] Mège M, Bonsergent C, Viry L, et al. Genetic diversity of equine piroplasmosis agents in Guadeloupe (Caribbeans): first report of Theileria haneyi, evaluation of diagnostic tools and impact of horse movement. Ticks Tick Borne Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41016326/

[8] Rüegg SR, Torgerson P, Deplazes P, et al. Age-dependent dynamics of Theileria equi and Babesia caballi infections in southwest Mongolia based on IFAT and/or PCR prevalence data from domestic horses and ticks. Parasitology. 2007. URL: https://pubmed.ncbi.nlm.nih.gov/17306055/

[9] Bashiruddin JB, Cammà C, Rebêlo E. Molecular detection of Babesia equi and Babesia caballi in horse blood by PCR amplification of part of the 16S rRNA gene. Vet Parasitol. 1999. URL: https://pubmed.ncbi.nlm.nih.gov/10435792/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[10] Lobanov VA, Peckle M, Massard CL, et al. Development and validation of a duplex real-time PCR assay for the diagnosis of equine piroplasmosis. Parasit Vectors. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29499748/

[11] Lei R, Wang X, Zhang D, et al. Rapid isothermal duplex real-time recombinase polymerase amplification (RPA) assay for the diagnosis of equine piroplasmosis. Sci Rep. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32139744/